TOKYO -- Fujifilm Holdings, whose experimental Ebola drug grabbed the spotlight amid an outbreak in West Africa, is working to strengthen its health care business by developing new treatments, the company's chief executive officer told The Nikkei.
Shigetaka Komori The Japanese company, long known for its photo film and office equipment, is now conducting clinical trials on cancer and Alzheimer's drugs, Chairman and CEO Shigetaka Komori said, expressing hopes for approval to begin sales in 2018.
